{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:55:30Z","timestamp":1758970530221},"reference-count":60,"publisher":"Informa Healthcare","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1517\/14656566.2.11.1805","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T00:31:16Z","timestamp":1115253076000},"page":"1805-1816","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacotherapy of hypertension in patients with diabetes mellitus"],"prefix":"10.1517","volume":"2","author":[{"given":"Prakash C","family":"Deedwania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK PROSPECTIVE DIABETES STUDY GROUP","year":"1998","journal-title":"Lancet"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","volume":"317","author":"UK PROSPECTIVE DIABETES STUDYGROUP","year":"1998","journal-title":"Br Med. J"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2337\/diacare.17.11.1247","volume":"17","author":"TARNOW L","year":"1994","journal-title":"Diabetes Care"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/1047-2797(93)90006-P","volume":"3","author":"DESTAFANO E FORD ES, NEWMAN J, et al","year":"1993","journal-title":"Ann. Epidemiol"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.2.145"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","volume":"340","author":"SYSTOLIC HYPERTENSION IN EUROPE TRIAL INVESTIGATORS","year":"1999","journal-title":"N Engl. j Med."},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","volume":"34","author":"RITZ E","year":"1999","journal-title":"Am. j Kidney Dis."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.jhh.1001117","volume":"14","author":"PRENCIPE M","year":"2000","journal-title":"J. Hum. Hypertens."},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0895-7061(00)00280-6","volume":"13","author":"KJELDSEN SE","year":"2000","journal-title":"Losartan Intervention For Endpoint. Am. J. Hypertens."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199810293391804","volume":"339","author":"GAINER JV","year":"1998","journal-title":"N Engl. I Med."},{"issue":"2","key":"CIT0025","first-page":"188","volume":"163","author":"WRIGHT JM","year":"2000","journal-title":"CMAJ"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","volume":"353","author":"HANSSON L","year":"1999","journal-title":"Lancet"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"THE HEART OUTCOMES EVALUATION STUDY INVESTIGATORS","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00004872-199917030-00018","volume":"17","author":"GALLETTI F","year":"1999","journal-title":"j Hypertens"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(91)90092-C","volume":"91","author":"BULLER GK","year":"1991","journal-title":"Am. Med."},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","volume":"355","author":"HEART OUTCOMES PREVENTION EVALUATION","year":"2000","journal-title":"Lancet"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199606203342507","volume":"334","author":"GOODFRIEND TL","year":"1996","journal-title":"N Engl. Med."},{"key":"CIT0033","first-page":"293","volume":"163","author":"WRIGHT JM","year":"2000","journal-title":"CMAJ"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19294"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/archinte.160.13.1905","volume":"160","author":"GROSSMAN E","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"CIT0036","first-page":"2084","volume":"58","author":"BAKRIS GL","year":"2000","journal-title":"D, et al.: ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. Kidney Int."},{"issue":"5","key":"CIT0038","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-8703(78)90303-4","volume":"95","author":"SHAH S","year":"1978","journal-title":"Am. Heart J."},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/0002-8703(93)90447-H","volume":"125","author":"WEIDMANN PO","year":"1993","journal-title":"Am. Heart J."},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","volume":"276","author":"SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM COOPERATIVE RESEARCH GROUP","year":"1996","journal-title":"JAMA"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/archinte.1991.00400070114014","volume":"151","author":"WARRANT J","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"CIT0043","first-page":"1852","volume":"330","author":"SISCOVICK DS","year":"1994","journal-title":"PSATY BM, et al.: Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl. J. Med."},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1056-8727(97)00100-1","volume":"11","author":"ZUANETTI G LATINI R","year":"1997","journal-title":"I Diabet. Complications"},{"key":"CIT0045","first-page":"905","volume":"342","author":"GRESS TW","year":"2000","journal-title":"For the atherosclerosis risk in communities study. N Engl. J. Med."},{"key":"CIT0046","first-page":"1008","volume":"7","author":"VETERANS ADMINISTRATION COOPERATIVE STUDY GROUP ON ANTIHYPERTENSIVE AGENTS","year":"1985","journal-title":"IV. Effect on plasma glucose and glucose tolerance. Hypertension"},{"key":"CIT0047","first-page":"982","volume":"128","author":"RAVID M","year":"1998","journal-title":"A randomised, controlled trial. Ann. Intern. Med."},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.2.6030.272","volume":"2","author":"DEACON SP","year":"1976","journal-title":"Br Med. J."},{"key":"CIT0049","first-page":"264","volume":"29","author":"KERR D","year":"1990","journal-title":"Pharmacol"},{"issue":"9","key":"CIT0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diab.40.9.1177","volume":"40","author":"HIRSCH IB","year":"1991","journal-title":"Diabetes"},{"key":"CIT0051","first-page":"85","volume":"1","author":"LYNGSOE J","year":"1992","journal-title":"SJOSTRAND H etal.: The effect of sustained release verapamil on glucose metabolism in patients with NIDDM. Drugs"},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"HANSSON L","year":"1998","journal-title":"Lancet"},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","volume":"338","author":"ESTACIO RO","year":"1998","journal-title":"N Eng]. J. Med."},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.21.4.597","volume":"21","author":"TATTI P","year":"1998","journal-title":"Diabetes Care."},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0002-9149(00)01199-1","volume":"86","author":"MESSERLI FH","year":"2000","journal-title":"Am. J. Cardiol"},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00005344-199805000-00005","volume":"31","author":"ANDERSEN P","year":"1998","journal-title":"J. Cardiovasc. Pharmacy]."},{"key":"CIT0058","first-page":"1967","volume":"283","author":"THE ALLHAT OFFICERS AND COORDINATORS FOR THE ALLHAT COLLABORATIVE RESEARCH GROUP","year":"2000","journal-title":"Major cardiovascular events in hypertensive patients randomised to doxazosin vs. chlorthalidone. JAMA"},{"key":"CIT0059","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archinte.1984.00350180116018","volume":"114","author":"BAUER JH","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0002-9343(87)90160-4","volume":"82","author":"LEENEN FHH, SMITH DL, FARAKS RM, REEVES RA,","year":"1987","journal-title":"Am. J. Med."},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.91.3.698","volume":"91","author":"LIEBSON PR","year":"1995","journal-title":"Circulation"},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.95.8.2007","volume":"95","author":"GOTTDIENER JS","year":"1997","journal-title":"Circulation"},{"issue":"7274","key":"CIT0064","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.321.7274.1440","volume":"321","author":"MOGENSEN CE","year":"2000","journal-title":"Br Med. J."},{"key":"CIT0069","first-page":"1751","volume":"1999","author":"LENNART HANSSON, LARS H LINDHOLM, TORD EKBOM et al.","journal-title":"Lancet"},{"key":"CIT0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","volume":"356","author":"HANSSON L","year":"2000","journal-title":"Lancet"},{"key":"CIT0071","first-page":"366","volume":"356","author":"BROWN MJ","year":"2000","journal-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) Lancet"},{"key":"CIT0072","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"LEWIS EJ","year":"1993","journal-title":"N Eng]. J. Med."},{"key":"CIT0073","first-page":"982","volume":"128","author":"RAVID M","year":"1998","journal-title":"A randomised, controlled trial. Ann. Intern. Med."},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-8-199304150-00001"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-10-199511150-00003"},{"key":"CIT0077","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.HYP.29.2.641","volume":"29","author":"LAZARUS JM","year":"1997","journal-title":"Hypertension"},{"issue":"2","key":"CIT0078","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005344-199302000-00017","volume":"21","author":"LUSCHER TF","year":"1993","journal-title":"J. Cardiovasc. Pharmacol"},{"issue":"5","key":"CIT0079","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1007774505445","volume":"11","author":"PITTROW DB","year":"1997","journal-title":"Cardiovasc. Drugs net"},{"issue":"2","key":"CIT0081","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1464-5491.1987.tb00855.x","volume":"4","author":"CORCORAN JS","year":"1987","journal-title":"Diabet. Med."},{"issue":"3","key":"CIT0082","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1291\/hypres.23.219","volume":"23","author":"SHIGIHARA T","year":"2000","journal-title":"Hyperteris. Res."},{"issue":"4","key":"CIT0083","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1523-1755.1998.00083.x","volume":"54","author":"BAKRIS GL","year":"1998","journal-title":"Kidney Int."},{"key":"CIT0087","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","volume":"16","author":"STAMLER J","year":"1993","journal-title":"Diabetes Care"},{"key":"CIT0088","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0895-4356(92)90197-U","volume":"45","author":"SNIDERMAN A","year":"1992","journal-title":"j Clin. Epidemiol"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2.11.1805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T23:16:59Z","timestamp":1550445419000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2.11.1805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1517\/14656566.2.11.1805"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2.11.1805","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}